Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adma Biologics (NQ: ADMA ) 13.75 +0.39 (+2.92%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4,090,238 Open 13.50 Bid (Size) 13.78 (1) Ask (Size) 13.95 (3) Prev. Close 13.36 Today's Range 13.47 - 13.95 52wk Range 3.060 - 13.95 Shares Outstanding 196,357,149 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session July 18, 2024 Via Benzinga Biotech Arvinas Stock Earns 82 RS Rating July 17, 2024 The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82. Via Investor's Business Daily Performance YTD +202.20% +202.20% 1 Month +24.89% +24.89% 3 Month +121.77% +121.77% 6 Month +159.92% +159.92% 1 Year +268.63% +268.63% More News Read More Denali Therapeutics Stock Gets Technical Rating Upgrade July 16, 2024 Via Investor's Business Daily 3 Millionaire-Making Stock Picks With Astounding Growth Potential July 13, 2024 Via InvestorPlace How Is The Market Feeling About ADMA Biologics? July 11, 2024 Via Benzinga Bull Run Alert: 3 Stocks Set to Soar in the Coming Months July 11, 2024 Via InvestorPlace Expert Ratings For ADMA Biologics July 09, 2024 Via Benzinga Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights June 20, 2024 Via Benzinga ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results May 10, 2024 Via Benzinga UroGen Pharma Stock Earns 91 RS Rating June 27, 2024 Via Investor's Business Daily Arcellx Stock Earns Relative Strength Rating Upgrade June 21, 2024 Via Investor's Business Daily Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87 June 20, 2024 Via Investor's Business Daily Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Via Investor's Business Daily Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade June 12, 2024 Via Investor's Business Daily Krystal Biotech Stock Sees RS Rating Jump To 91 June 11, 2024 Via Investor's Business Daily A Closer Look at 6 Analyst Recommendations For ADMA Biologics March 26, 2024 Via Benzinga Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday May 10, 2024 Via Benzinga ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 09, 2024 Via Benzinga ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Chart Of The Day: ADMA Biologics - Hitting New Highs May 06, 2024 Via Talk Markets ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 May 02, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® March 11, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA Biologics to Participate in the Raymond James Institutional Investor Conference March 05, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.